For those using alternative metabolic diets as weight-loss solutions, this isn’t the end of the world. For those using ketosis as a treatment for a neurological disorder, a slip up can be detrimental.
Our newest CVR is here [https://drive.google.com/file/d/16x6erGdbdY9NvxKIXfslD8TXYCqRoHy2/view]. Glucose Transporter Type1 Deficiency Syndrome (Glut1DS) a rare genetic condition that impairs brain metabolism. It is caused by a mutation in the SLC2A1 gene. More than 100 different types of mutations and deletions of this gene have been found to date in Glut1 Deficiency patients. The number of patients diagnosed is currently thought to number in the hundreds. Recent studies have estimated true p
When the quest for good clinical data is arduous, researchers and drug developers often contract tunnel vision. Certain endpoints are established and analysis begins, the more objective, the better. But as endpoints become more specific, and researchers arrive at a clearer understanding of what they are looking for, the landscape of information they are relying on shrinks. These blinders are a necessary part of getting a treatment through rigorous approval processes, but the more they block, the